These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3304918)

  • 41. Bactericidal activity of ofloxacin versus roxithromycin in the treatment of Streptococcus pneumoniae.
    Shah PM; Schäfer V; Hubener T; Metz C; Stille W
    Drugs; 1987; 34 Suppl 1():9-13. PubMed ID: 3481332
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro activity of LY146032 against gram-positive bacteria.
    Silva M; Jacobus NV; Gorbach SL
    Diagn Microbiol Infect Dis; 1988 Feb; 9(2):79-85. PubMed ID: 2838217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic sensitivity of comedonal Propionibacterium acnes.
    Guin JD; Huber DS; Gielerak PL
    Acta Derm Venereol; 1979; 59(6):552-54. PubMed ID: 94223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria.
    Cohen MA; Griffin TJ; Bien PA; Heifetz CL; Domagala JM
    Antimicrob Agents Chemother; 1985 Dec; 28(6):766-72. PubMed ID: 3866513
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
    Kuriyama T; Karasawa T; Nakagawa K; Yamamoto E; Nakamura S
    Oral Microbiol Immunol; 2002 Apr; 17(2):132-5. PubMed ID: 11929563
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.
    Benson C; Segreti J; Kessler H; Hines D; Goodman L; Kaplan R; Trenholme G
    Eur J Clin Microbiol; 1987 Apr; 6(2):173-8. PubMed ID: 2954818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
    Kuenzi B; Segessenmann C; Gerber AU
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigations on ofloxacin: antibacterial activity and influence on the immune system.
    Pulverer G; Peters G
    Infection; 1986; 14 Suppl 4():S245-7. PubMed ID: 3102386
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in vivo activity of DL-8280, a new oxazine derivative.
    Sato K; Matsuura Y; Inoue M; Une T; Osada Y; Ogawa H; Mitsuhashi S
    Antimicrob Agents Chemother; 1982 Oct; 22(4):548-53. PubMed ID: 6960805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibacterial oxazolidinones. In vitro activity of a new analogue, E3709.
    Brumfitt W; Hamilton-Miller JM
    Diagn Microbiol Infect Dis; 1992; 15(7):621-5. PubMed ID: 1424519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative in-vitro activities of A-56268 (TE-031) and erythromycin against 306 clinical isolates.
    Liebers DM; Baltch AL; Smith RP; Hammer MC; Conroy JV; Shayegani M
    J Antimicrob Chemother; 1988 May; 21(5):565-70. PubMed ID: 2968968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro activity of U-57930E, a new clindamycin analog, against aerobic gram-positive bacteria.
    Ahonkhai VI; Cherubin CE; Shulman MA; Jhagroo M; Bancroft U
    Antimicrob Agents Chemother; 1982 Jun; 21(6):902-5. PubMed ID: 7114838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative in-vitro activity of RP 59500.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1992 Jul; 30 Suppl A():39-44. PubMed ID: 1399949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Teichomycin: in-vitro and in-vivo evaluation in comparison with other antibiotics.
    Pallanza R; Berti M; Goldstein BP; Mapelli E; Randisi E; Scotti R; Arioli V
    J Antimicrob Chemother; 1983 May; 11(5):419-25. PubMed ID: 6223907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clindamycin, erythromycin, and the newer macrolides.
    Raebel MA; Browne BA
    Clin Podiatr Med Surg; 1992 Apr; 9(2):409-23. PubMed ID: 1586909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative activity of ofloxacin and seven other antimicrobials against urea-splitting microorganisms.
    Torres A; Fernández-Roblas R; Méndez B; Soriano F
    Infection; 1986; 14 Suppl 4():S233-6. PubMed ID: 3469152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ocular infections: antibiotics and bacterial adhesion on biomaterials used in ocular surgery.
    Marone P; Perversi L; Monzillo V; Maserati R; Antoniazzi E
    Ophthalmologica; 1995; 209(6):315-8. PubMed ID: 8751338
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Reactive oxygen species and the bacteriostatic and bactericidal effects of isoconazole nitrate.
    Czaika VA; Siebenbrock J; Czekalla F; Zuberbier T; Sieber MA
    Mycoses; 2013 May; 56 Suppl 1():16-22. PubMed ID: 23574020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibiogram pattern of oral microflora in periodontic children of age group 6 to 12 years: a clinicomicrobiological study.
    Fysal N; Jose S; Kulshrestha R; Arora D; Hafiz KA; Vasudevan S
    J Contemp Dent Pract; 2013 Jul; 14(4):595-600. PubMed ID: 24309334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro antibacterial activity of NB-003 against Propionibacterium acnes.
    Pannu J; McCarthy A; Martin A; Hamouda T; Ciotti S; Ma L; Sutcliffe J; Baker JR
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4211-7. PubMed ID: 21746943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.